Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of GLP-1 Agonist Therapy on Insulin Secretion in Adults With Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a Randomized, Open-label, Cross-over Trial

NCT04731272 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04731272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04731272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of GLP-1 Agonist Therapy on Insulin Secretion in Adults With Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a Randomized, Open-label, Cross-over Trial
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Recruiting
Start date
July 16, 2021
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abnormal glucose tolerance, cystic fibrosis, diabetes, pancreatic insufficiency